Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack — the drugmaker accused two of the companies of…
Hypertension, or high blood pressure, is known to have a direct impact on heart attack and stroke risk — but a new study has revealed its surprising link to brain health.
In a large, randomized trial, researchers led by First Hospital…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us